Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4518562
Max Phase: Preclinical
Molecular Formula: C40H47F2N7O10
Molecular Weight: 823.85
Molecule Type: Unknown
Associated Items:
ID: ALA4518562
Max Phase: Preclinical
Molecular Formula: C40H47F2N7O10
Molecular Weight: 823.85
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H]1NC(=O)[C@@H]2CCCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](Cc2cc(F)cc(F)c2)NC(=O)Nc2ccc3c(c2)OCO3)[C@H](C)OC(=O)[C@@H]2CCCN2C1=O
Standard InChI: InChI=1S/C40H47F2N7O10/c1-21-36(52)49-14-6-9-30(49)39(55)59-22(2)33(38(54)48-13-5-8-29(48)37(53)47-12-4-3-7-28(47)35(51)43-21)46-34(50)27(17-23-15-24(41)18-25(42)16-23)45-40(56)44-26-10-11-31-32(19-26)58-20-57-31/h10-11,15-16,18-19,21-22,27-30,33H,3-9,12-14,17,20H2,1-2H3,(H,43,51)(H,46,50)(H2,44,45,56)/t21-,22-,27-,28-,29-,30-,33-/m0/s1
Standard InChI Key: RRCVSNDNPXUVFE-AGLXQPSFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 823.85 | Molecular Weight (Monoisotopic): 823.3352 | AlogP: 1.72 | #Rotatable Bonds: 6 |
Polar Surface Area: 205.02 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 17 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.05 | CX Basic pKa: | CX LogP: 1.33 | CX LogD: 1.33 |
Aromatic Rings: 2 | Heavy Atoms: 59 | QED Weighted: 0.31 | Np Likeness Score: 0.02 |
1. (2018) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase, |
Source(1):